Peptide Academy · Approved peptides · Education only
Leuprolide: What FDA Approved, Explained Simply
By BioLabs Research · Peptide Academy › Approved Peptides
Here's one of the strangest tricks in pharmacology: a 'go' signal that, if you keep it switched on, turns into a 'stop' signal. Leuprolide is the classic example.
On this page we'll keep it simple: what leuprolide is, what it does according to the official FDA label, and exactly what FDA approved. Nothing here is advice on using a medicine. Approved medicines are prescribed by licensed clinicians, and the official label is always the controlling text.
What it is
Leuprolide is a synthetic analogue of gonadotropin-releasing hormone (GnRH), a small peptide from the hypothalamus that tells the pituitary to release the hormones that drive the testes and ovaries. Several different leuprolide products are approved, each under its own application.
What it does
According to section 12.1 of the FDA label, leuprolide is a GnRH agonist that acts as an inhibitor of gonadotropin secretion. After an initial stimulation, continued exposure suppresses testicular and ovarian steroid production. The label notes this effect is reversible when therapy stops. Think of a doorbell held down so long the household stops answering.
For a deeper dive, see the peer-reviewed review: Expert Opin Drug Deliv 2012 — 'Leuprolide acetate: pharmaceutical use and delivery potentials' (PubMed 22335366).
What FDA approved
Labelled indication: Varies by product. Examples from current FDA labels: treatment of advanced prostate cancer (NDA 020517 and other products); management of endometriosis, including pain relief and reduction of endometriotic lesions (NDA 020011). Other leuprolide products carry other labelled indications.
Each leuprolide product has its own label, strength and indication. Approval of one does not extend to the others.
Regulatory status at a glance
| Item | Status | Source |
|---|---|---|
| Application | NDA 019010 | Drugs@FDA |
| Original approval date | April 9, 1985 (first leuprolide approval; later products approved under NDA 019732 on January 26, 1989, NDA 020011 and others) | openFDA |
| Labelled indication | As quoted above | DailyMed |
| Boxed warning | None on the labels checked (NDA 020517, NDA 020011) | DailyMed |
| 503A bulks list | Not applicable: this is an FDA-approved product | — |
A common misunderstanding
Leuprolide is a good lesson in why 'the molecule is approved' is the wrong way to think. FDA approves products, one application at a time.
What FDA approval actually means
Here's the part most people get wrong. FDA approval is narrow. It covers a specific product, from a specific manufacturer, for a specific use, in a specific group of patients, with a specific label. The approval does not belong to the molecule floating around in the world. A chemical with the same name, sold by someone else for any other purpose, is not an approved drug. That's why we quote the label's own indication and nothing more.
How we checked these facts
Every regulatory fact on this page comes from an official U.S. government source: the Drugs@FDA database (and its openFDA API) for the application number and approval date, and the current FDA label on DailyMed for the indication, boxed warning and mechanism. Mechanism background also comes from a peer-reviewed review indexed in PubMed. We don't reproduce usage instructions from labels. This is an education page, not a guide to using any medicine.
Why approved peptides matter for peptide science
Approved peptides prove that peptide research can turn into real medicines. They also show how high the bar is: controlled human trials, manufacturing inspections, a written label, and safety monitoring that continues after approval. Most peptides you read about online never got anywhere near that bar. Chapter 7 of the Academy explains where the line sits.
FAQ
Why does a GnRH agonist lower hormone levels?
Per the label, after an initial stimulation, continued exposure suppresses the pituitary signal to the testes and ovaries.
Is every leuprolide product approved for the same thing?
No. Indications differ by product and label.
Is this page medical advice?
No. It is education only. Talk to a licensed healthcare professional about any medicine.
References: Drugs@FDA; openFDA; DailyMed label; PubMed review; Drugs@FDA NDA 019732; DailyMed label NDA 020011.